Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
about
Drug-induced liver injury: a clinical updateDrug-induced liver injury: present and futureHepatotoxicity observed in clinical trials of aplaviroc (GW873140)Acute liver failure including acetaminophen overdoseHepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical CharacteristicsCase Characterization, Clinical Features and Risk Factors in Drug-Induced Liver InjuryThe Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic InitiativeHepatotoxicity by Drugs: The Most Common Implicated AgentsScientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United StatesRUCAM in Drug and Herb Induced Liver Injury: The UpdateCauses, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospitalThe Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?Update on Advances in Research on Idiosyncratic Drug-Induced Liver InjuryDrug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment OptionsDrug Induced Steatohepatitis: An Uncommon Culprit of a Common DiseaseHerbal hepatotoxicity: challenges and pitfalls of causality assessment methodsAtypical causes of cholestasisDrug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?Causality assessment in hepatotoxicity by drugs and dietary supplementsPathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Biomarkers in DILI: One More Step ForwardThe Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review ArticleHLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicitySelected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohortMulticenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumoniaHigh Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD CohortDrug-induced liver injury: recent advances in diagnosis and risk assessment.Research Advances on Hepatotoxicity of Herbal Medicines in ChinaCurrent and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database.The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study.Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics Approaches.Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathwaysDrug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or NecrosisAge and sex dependent changes in liver gene expression during the life cycle of the rat.Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs?
P2860
Q24617074-AB956227-7C48-4074-9554-032716E31231Q24630227-BB164218-85AF-4B28-8C4A-B134485F25E3Q24641929-DA578C0C-0984-464C-AC4D-AC427C83AD78Q24647134-8659BEA9-60EA-45F7-965C-6A07C00F57D6Q26748911-FE43FBE1-DAF4-45A0-B443-6142229E7AA7Q26749054-3D81AC6D-6540-43F6-80DC-3BF4EBDE0A0AQ26764776-179897CA-A04B-40B5-B9C9-792CD7C7A204Q26767251-42B7F4A4-EC5E-40CF-8A06-823483DD3BD8Q26767376-1DDA0BB0-6700-4941-B224-5368D2FB4F13Q26771817-D5A571BD-0D57-47E3-84B5-F5108BA69BC2Q26772063-5DB7271B-3AD1-4405-B281-2A971B710085Q26772999-770484A4-7FB7-402C-B5D2-DD7EB4F3387FQ26779078-0DE51D4D-54C5-4234-8498-E7D30389C3E2Q26781892-FB19B32D-F788-48DE-92F2-CA66BD8746D7Q26798157-7D6AB94F-C3E6-48F8-8E56-6BD3D69A98D8Q26824747-F8CD4289-1CAB-4593-AC73-89404D15B9F7Q27013650-9936AFF4-F050-439F-82FC-C696B9916DBBQ27030822-146FC7B5-3A8E-472A-9B86-3E146D284DF9Q27488354-A4518F31-DD90-4264-9AE6-1F6AB5BC3596Q27690772-97EE3561-A8C6-4EF3-AD2C-90FA260B0B13Q28071799-35A91C69-C093-41FD-878F-3F5705825392Q28075382-3E4BA272-1CAC-45DF-BDF4-B13807745A6CQ28534593-E732A9D1-6A66-43DB-973A-61F11F627FA2Q28537826-C5CD2B99-1574-440E-B3DD-4B486664B39CQ28542714-9511FB13-09D8-4EE0-BD8E-3E0C422AE674Q28550768-4DD383DD-C294-4FCD-A67B-59D339646117Q30235089-F7BD94D0-E52E-4396-A37A-477189CD834CQ30239062-FFF15BE3-FCDA-4EA1-8764-57962BEC878AQ30277969-9E7248DE-9641-4CDE-AFB7-BAD601C7DCD4Q30838395-4A63DDE6-0E48-4121-B098-096615F8C031Q30852962-5C42F69F-DC51-451A-8C8A-0896E5EC229EQ31139774-0744A530-3B4C-4207-A4DA-C5C99EF18C4AQ33442111-211D4772-498A-4257-BF6A-9283DC82616CQ33563872-DF2C4D5A-5F2D-48B7-9764-C6CE8822FEEDQ33590645-1583F064-B129-44B8-8F40-EDBFCB5FD18EQ33648066-C1421C8A-43E8-4CDD-BE88-69AA9023F75AQ33687525-B6E0FD7F-4918-4913-A39A-2FAE606BA34AQ33755165-233C4941-3B4A-4340-B7A6-AC0424B159E5Q33758968-42CE56D0-5D7B-4355-96FF-FC0E41644996Q33866245-DD862671-1B63-4762-8096-8D5D879CA825
P2860
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Drug-induced liver injury: an ...... egistry over a 10-year period.
@ast
Drug-induced liver injury: an ...... egistry over a 10-year period.
@en
Drug-induced liver injury: an ...... egistry over a 10-year period.
@nl
type
label
Drug-induced liver injury: an ...... egistry over a 10-year period.
@ast
Drug-induced liver injury: an ...... egistry over a 10-year period.
@en
Drug-induced liver injury: an ...... egistry over a 10-year period.
@nl
prefLabel
Drug-induced liver injury: an ...... egistry over a 10-year period.
@ast
Drug-induced liver injury: an ...... egistry over a 10-year period.
@en
Drug-induced liver injury: an ...... egistry over a 10-year period.
@nl
P2093
P1433
P1476
Drug-induced liver injury: an ...... egistry over a 10-year period.
@en
P2093
Africa Borras
Aina Soler
Angeles Pizarro
Beatriz García-Muñoz
Elena García-Ruiz
Gloria Pelaez
Javier Salmerón
Joan Costa
José Antonio Durán
José María Navarro
P304
P356
10.1053/J.GASTRO.2005.05.006
P407
P577
2005-08-01T00:00:00Z